Clinical Trial Update: Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sugammadex with neostigmine in patients with cirrhosis undergoing liver resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Disease

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Cairo University | Conditions: Cirrhosis and Chronic Liver Disease | Phase 4 | Status: COMPLETED